Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025 It was another year of tight margins and tense boardrooms at Australia’s ASX-listed cannabis firms, as […]
Althea creditors to recover four cents in the dollar under DOCA by Adam Sheldon August 20, 2025August 20, 2025
From visions of global leadership to an asset sale: where did it go wrong for Althea’s medical aspirations? by Steve Jones May 8, 2025May 8, 2025
Tasmanian Botanics to ‘breathe new life’ into Althea brand as it snaps up pharma assets for $1 million by Martin Lane and Steve Jones May 7, 2025May 8, 2025
Althea considers exiting medicinal cannabis market amid sales collapse by Steve Jones April 30, 2025April 30, 2025
Althea claims profitability ‘is close’ despite pharmaceutical nosedive by Steve Jones March 3, 2025March 4, 2025
Changes on the horizon but exit of pharmaceutical market ‘not currently on the table’, says Althea CEO by Steve Jones February 20, 2025February 20, 2025
Althea committed to ‘transparency and corrective action’ after failure to lodge mandatory ASX notices by Steve Jones December 12, 2024December 12, 2024
